Digital Intervention Targeting Cancer-related Cognitive Impairments
Launched by HAUKELAND UNIVERSITY HOSPITAL · Nov 15, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new digital program designed to help people who have had cancer treatment and are experiencing difficulties with thinking and memory, often called cognitive impairments. These issues can make everyday tasks harder and sometimes last for a long time after treatment. The study will explore how well this digital intervention works, who benefits the most from it, and how easy it is for participants to use both the program and the study setup. Participants will also share their feedback on the program to help improve it.
To join the study, participants should be between 18 and 65 years old, have completed their cancer treatment at least six months ago, and feel they have memory or thinking problems that affect their daily life. They also need to be comfortable using Norwegian and have access to the internet on a computer, tablet, or smartphone. However, individuals with certain neurological conditions, a history of severe head injuries, or significant mental health issues may not be eligible. The trial is not yet recruiting participants, but it aims to gather valuable information that could lead to better support for cancer survivors facing cognitive challenges.
Gender
ALL
Eligibility criteria
- • The target group consists of individuals who have previously undergone cancer treatment (N=60).
- Inclusion Criteria:
- • 1. Age between 18 and 65 years,
- • 2. Self-reported cognitive difficulties that are perceived to impact daily functioning (PCI \<44 FACT-Cog),
- • 3. Have received cancer treatment,
- • 4. Completed curative treatment at least six months prior,
- • 5. Proficient in speaking and writing Norwegian,
- • 6. Access to a computer, tablet, or smartphone, and the internet.
- Exclusion Criteria:
- • 1. Neurological disorders (e.g., ADHD, MS, autism),
- • 2. History of severe head injury,
- • 3. Current moderate or severe depression (PHQ-9 score \>14),
- • 4. Previously diagnosed with serious mental disorders, such as substance abuse, bipolar disorder, or psychotic disorders.
About Haukeland University Hospital
Haukeland University Hospital, located in Bergen, Norway, is a leading academic medical center renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge clinical studies that aim to advance healthcare outcomes. With a multidisciplinary team of healthcare professionals and researchers, Haukeland University Hospital fosters collaboration and knowledge exchange, ensuring that trials are conducted with the highest standards of ethics, safety, and scientific rigor. Its strategic focus on translational research enhances the bridge between laboratory discoveries and real-world applications, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported